Review
doi: 10.1080/02841866409134063.
RADIOACTIVE YTTRIUM 90: A REVIEW OF ITS PROPERTIES, BIOLOGICAL BEHAVIOR, AND CLINICAL USES
- PMID: 14203057
- DOI: 10.1080/02841866409134063
Item in Clipboard
Review
RADIOACTIVE YTTRIUM 90: A REVIEW OF ITS PROPERTIES, BIOLOGICAL BEHAVIOR, AND CLINICAL USES
Acta Radiol Ther Phys Biol.
1964 Aug.
No abstract available
Similar articles
-
[HYPOPHYSIOLYSIS WITH RADIOACTIVE YTTRIUM IN THE TREATMENT OF ADVANCED BREAST CANCER].Lyon Chir. 1965 Jan;61:94-5. Lyon Chir. 1965. PMID: 14298515 French. No abstract available.
-
[HYPOPHYSECTOMY WITH RADIOACTIVE YTTRIUM IN THE TREATMENT OF BREAST CANCER IN ADVANCED STAGES].Lyon Chir. 1964 Nov;60:872-3. Lyon Chir. 1964. PMID: 14268557 French. No abstract available.
-
[DISCUSSIONS ON MAMMARY CANCER. 6. STATE OF PATIENTS WITH METASTATIC MAMMARY CANCER AFTER TREATMENT BY HYPOPHYSECTOMY WITH RADIOACTIVE YTTRIUM].Jaarb Kankeronderz Kankerbestrijd Ned. 1963;13:75-88. Jaarb Kankeronderz Kankerbestrijd Ned. 1963. PMID: 14184131 Dutch. No abstract available.
-
[MODERN RADIOTHERAPY OF MALIGNANT TUMORS].Med Klin. 1964 Jan 31;59:161-5. Med Klin. 1964. PMID: 14127045 Review. German. No abstract available.
-
RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE.N Engl J Med. 1965 Mar 18;272:569-74 CONCL. doi: 10.1056/NEJM196503182721106. N Engl J Med. 1965. PMID: 14248733 Review. No abstract available.
Cited by
-
Transarterial Radioembolization for Management of Hepatocellular Carcinoma.Oncologist. 2024 Feb 2;29(2):117-122. doi: 10.1093/oncolo/oyad327. Oncologist. 2024. PMID: 38128565 Free PMC article.
-
Defining a New Classification System for the Surgical Management of Neuroendocrine Tumor Liver Metastases.J Clin Med. 2023 Mar 23;12(7):2456. doi: 10.3390/jcm12072456. J Clin Med. 2023. PMID: 37048539 Free PMC article. Review.
-
Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures.Cancers (Basel). 2021 Dec 19;13(24):6368. doi: 10.3390/cancers13246368. Cancers (Basel). 2021. PMID: 34944988 Free PMC article. Review.
-
Targeted Therapy With Immunoconjugates for Multiple Myeloma.Front Immunol. 2020 Jun 19;11:1155. doi: 10.3389/fimmu.2020.01155. eCollection 2020. Front Immunol. 2020. PMID: 32636838 Free PMC article. Review.
-
90Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's Lymphoma.Commun Biol. 2019 Feb 26;2:79. doi: 10.1038/s42003-019-0327-4. eCollection 2019. Commun Biol. 2019. PMID: 30820474 Free PMC article.